leisure time -WSS

leisure time

author：knowledge 2025-09-30 00:36:55 - browse：6

insulin biosimilar — Last week, the FDA released a trio of guidelines clarifying the way they plan to evaluate devices that go through the 510(k) pathway. Jacquelyn Martin/AP

Five years after promising to fix a flawed regulatory pathway widely used by medical device manufacturers, the Food and Drug Administration has issued new guidelines to improve its so-called 510(k) program that has long been lambasted for letting risky devices fall through the cracks.

Most medical device companies do not have to test their products on people in order to secure clearance from the FDA — they simply have to show they’re “substantially equivalent” to devices already on the market, called “predicates.” This process is the 510(k) pathway, and accounts for the vast majority of new medical devices launched on the market each year. Devices cleared through this pathway include X-ray machines, muscle stimulators, and wheelchairs.

Last week, the FDA released a trio of guidelines clarifying the way it plans to evaluate devices that go through the 510(k) pathway. The agency is asking manufacturers to avoid predicate devices that were recalled due to a “design-related” issue or have “unmitigated” safety concerns. Manufacturers should submit flow charts explaining why they chose their predicate device. If they have to choose one with a recall history or safety issues, they should explain how the new device addresses those problems. The FDA may also ask the manufacturer for clinical data in this case.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Most antidepressants don't work on kids, teens, study finds

WSS

Fauci's latest grilling in Congress: 9 hours, behind closed doors

At JPM 2024, hospital systems pitch financial strength to investors

Crowdfunding for medical bills sidesteps core problem, author says

Is it ever OK for doctors to lie to their patients?

Profiling embryos to choose those with higher IQs is almost a reality

Arena BioWorks launches in Cambridge to speed drug discovery

hotspot

leisure time

Wikipedia

Medical leaders decry Supreme Court decision on affirmative action

Medicare Advantage coverage denials need scrutiny, senators say

In Memoriam: Notable people who died in 2023

Welsh Carson private equity firm escapes from FTC antitrust case

Affirmative action in medical school literally saved lives

Black vets could get higher VA benefits if race not used in lung test

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Boston Scientific acquires urology company Axonics for $3.7 billion

Sports medicine is finally prioritizing gender equality

Lawmakers grill UnitedHealth CEO on Change cyberattack

explore

AI for drug discovery: Experts on separating hype from reality

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Physician assistants need a new name. Here's what it should be

Stories you might have missed in 2023: health, science, medicine

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

focus

entertainment

focus

focus